Articles

Results 1 to 5 of 280
Most popular |Most recent


Dissatisfied patent reexamination plaintiff contends standing conferred by statute

USA - November 13 2014 A consumer-interest organization that was dissatisfied by a Board of Patent Appeals and Interferences (BPAI) ruling in the appeal of a patent…

Debra S. Dunne, John D. Garretson, Chris A. Johnson, Madeleine M. McDonough.

Ninth Circuit rules out state’s claims in class settlement with fetal-gender testing co

USA - November 13 2014 The Ninth Circuit Court of Appeals has enjoined California's effort to obtain restitution on behalf of individual citizens bound by the bargainedfor…

Debra S. Dunne, John D. Garretson, Chris A. Johnson, Madeleine M. McDonough.

Bio-Rad agrees to pay $55 million to resolve SEC bribery charges

USA - November 13 2014 A California-based clinical diagnostic and life science research company has reportedly agreed to pay $55 million to resolve U.S. Securities and…

Debra S. Dunne, John D. Garretson, Chris A. Johnson, Madeleine M. McDonough.

FTC settles deceptive sales-tactics claims against MPHJ Technology

USA - November 13 2014 The U.S. Federal Trade Commission (FTC) has agreed to settle claims that MPHJ Technology Investments, LLC—a patent-assertion entity (PAE)—and company…

Debra S. Dunne, John D. Garretson, Chris A. Johnson, Madeleine M. McDonough.

RAND Corp. predicts $44.2 billion in savings with biosimilars

USA - November 13 2014 The Rand Corp. has issued a perspective titled "The Cost Savings Potential of Biosimilar Drugs in the United States." It predicts that "biosimilars…

Debra S. Dunne, John D. Garretson, Chris A. Johnson, Madeleine M. McDonough.